Comparison between LDR and HDR brachytherapy boost to the tumor bed in the conservative treatment of stage I and II breast cancer

Author(s):  
B. Guix ◽  
F. Finestres ◽  
I. Henrı́quez ◽  
A. Martinez ◽  
J.I. Tello ◽  
...  
Brachytherapy ◽  
2008 ◽  
Vol 7 (2) ◽  
pp. 145
Author(s):  
Magda Kubaszewska ◽  
Magdalena Dymnicka ◽  
Janusz Skowronek ◽  
Adam Chichel ◽  
Marek Kanikowski

2002 ◽  
Vol 178 (11) ◽  
pp. 615-623 ◽  
Author(s):  
Csaba Polgár ◽  
János Fodor ◽  
Zsolt Orosz ◽  
Tibor Major ◽  
Zoltán Takácsi-Nagy ◽  
...  

2001 ◽  
Vol 60 ◽  
pp. S18
Author(s):  
M. Kawczynska ◽  
W. Bulski ◽  
A. Olszewska ◽  
J. Lyczek ◽  
A. Kulik

1992 ◽  
Vol 10 (6) ◽  
pp. 976-983 ◽  
Author(s):  
A S Lichter ◽  
M E Lippman ◽  
D N Danforth ◽  
T d'Angelo ◽  
S M Steinberg ◽  
...  

PURPOSE Mastectomy versus excisional biopsy (lumpectomy) plus radiation for the treatment of stage I and II breast cancer was compared in a prospective randomized study. PATIENTS AND METHODS From 1979 to 1987, 247 women were randomized and 237 were treated on this study. All patients received a full axillary dissection and all node-positive patients received adjuvant chemotherapy with cyclophosphamide and doxorubicin. Radiation consisted of external-beam therapy to the whole breast with or without supraclavicular nodal irradiation followed by a boost to the tumor bed. RESULTS The minimum time on the study was 18 months and the median time on the study was 68 months. No differences in overall survival or disease-free survival were observed. Actuarial estimates at 5 years showed that 85% of mastectomy-treated patients were alive compared with 89% of the lumpectomy/radiation patients (P2 = .49; 95% two-sided confidence interval [CI] about this difference, 0% to 9% favoring lumpectomy plus radiation). The probability of failure in the irradiated breast was 12% by 5 years and 20% by 8 years according to actuarial estimates. Of 15 local breast failures, 14 were treated with and 12 were controlled by mastectomy; the ultimate local-regional control was similar in both arms of the trial. CONCLUSION These data add further weight to the conclusion that breast conservation using lumpectomy and breast irradiation is equivalent to mastectomy in terms of survival and ultimate local control for stage I and II breast cancer patients.


2021 ◽  
Vol 158 ◽  
pp. S87-S89
Author(s):  
A. La Rosa de los Ríos ◽  
B. Quiles ◽  
J.L. Guinot ◽  
M. Tortajada ◽  
M. Santos ◽  
...  

1993 ◽  
Vol 79 (4) ◽  
pp. 258-261 ◽  
Author(s):  
Gregorio Moro ◽  
Emanuele Ciambellotti

Aims and backgrounds This paper describes the evaluation of a personal series of 106 breast cancer patients, aged 28-75 years (average, 54), treated between 1988 and 1971, to determine the success of a conservative protocol proposed as a means of combining radicality with a better cosmetic result, less alteration of the body image and an improved quality of life. Methods All the patients were operated with quadrantectomy and excision of axillary lymph nodes, followed by radiotherapy: 50 Gy to the whole breast plus 10 Gy on the tumor bed (boost irradiation). Adjuvant hormone and/or chemotherapy was also administered in 71/106 cases. The mean follow-up was 22.3 months. Cosmetic assessment was subjective and objective (asymmetry, loss of volume, retraction). All patients were photographed. Results The subjective judgements were: excellent 79, satisfactory 25, and poor 2, compared with objective assessments of 72, 20 and 14, respectively. Patients with poor esthetic results were almost all either T2 or treated with chemotherapy. Conclusions Conservative treatment of breast cancer using integrated irradiation and surgery can therefore attain the required objective of eradication of the cancer while maintaining a satisfactory esthetic and therefore good psychologic outcome.


2001 ◽  
Vol 37 ◽  
pp. S186-S187
Author(s):  
B. Guix ◽  
I. Henríquez ◽  
F. Finestres ◽  
A. Martínez ◽  
J.I. Tello ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document